Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Holmes

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Journal of Affective Disorders|July 10, 2002
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesClive Ballard, Mary Johnson, Margaret Piggott, et al.
Dementia and Geriatric Cognitive Disorders|February 22, 2011
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's diseaseAlistair Burns, Elaine Perry, Clive Holmes, et al.
Journal of Alzheimer'S Disease : JAD|April 26, 2024
The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic DrugCalum Marr, Bethany McDowell, Clive Holmes, et al.
Synapse (New York, N.Y.)|August 1, 2007
Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive declineMargaret A Piggott, Clive G Ballard, Elise Rowan, et al.
Neuropathology and Applied Neurobiology|December 10, 2014
Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3βJay Amin, Claire Paquet, Alex Baker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2020
Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical studyJay Amin, Delphine Boche, Zoe Clough, et al.
Brain : a Journal of Neurology|June 4, 2019
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's diseaseJames A R Nicoll, George R Buckland, Charlotte H Harrison, et al.
Translational Psychiatry|August 5, 2020
Neuroinflammation in dementia with Lewy bodies: a human post-mortem studyJay Amin, Clive Holmes, Robert B Dorey, et al.
Brain : a Journal of Neurology|August 15, 2013
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunizationElina Zotova, Viraj Bharambe, Matthew Cheaveau, et al.
Consciousness and Cognition|November 19, 2002
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortexClive G Ballard, Jennifer A Court, Margaret Piggott, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Journal of Affective Disorders|July 10, 2002
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodiesClive Ballard, Mary Johnson, Margaret Piggott, et al.
Dementia and Geriatric Cognitive Disorders|February 22, 2011
A double-blind placebo-controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's diseaseAlistair Burns, Elaine Perry, Clive Holmes, et al.
Journal of Alzheimer'S Disease : JAD|April 26, 2024
The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic DrugCalum Marr, Bethany McDowell, Clive Holmes, et al.
Synapse (New York, N.Y.)|August 1, 2007
Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive declineMargaret A Piggott, Clive G Ballard, Elise Rowan, et al.
Neuropathology and Applied Neurobiology|December 10, 2014
Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3βJay Amin, Claire Paquet, Alex Baker, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 24, 2020
Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical studyJay Amin, Delphine Boche, Zoe Clough, et al.
Brain : a Journal of Neurology|June 4, 2019
Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's diseaseJames A R Nicoll, George R Buckland, Charlotte H Harrison, et al.
Translational Psychiatry|August 5, 2020
Neuroinflammation in dementia with Lewy bodies: a human post-mortem studyJay Amin, Clive Holmes, Robert B Dorey, et al.
Brain : a Journal of Neurology|August 15, 2013
Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunizationElina Zotova, Viraj Bharambe, Matthew Cheaveau, et al.
Consciousness and Cognition|November 19, 2002
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortexClive G Ballard, Jennifer A Court, Margaret Piggott, et al.
Pageof 13